agitg trial news

Trial Recruitment

AGITG Trial news: The AGITG currently has nine studies open to recruitment and seven studies in follow up.

The table below details the AGITG trials that are currently accruing patients.

Recruited Target Recruitment Period (months) Date of First Site Open (ANZ) Number of Sites Open 
DYNAMIC-III (Colon cancer) 653 1000 54 09 October 2017 42
DYNAMIC-Pancreas (Pancreatic cancer) 98 438 54 01 March 2019 26
GENESCREEN 5-FU (Pan Tumour) 41 50 50 1 February 2021 2
INTEGRATE IIb (Gastro-oesophageal cancer) 60 450 24 28 April 2021 24
LICPIC (Colorectal cancer) 62 100 110 11 September 2018 2
MASTERPLAN (Pancreatic cancer) 20 120 48 01 October 2019 11
NABNEC (Neuroendocrine tumours) 59 58 54 15 September 2016 18
OXTOX (Colorectal cancer) 8 100 18 18 December 2020 7
PALEO (Oesophageal cancer) 5 54 36 16 September 2019 1
RANDOMS (Pancreatic cancer) 7 60 38 14 December 2020 3
RENO (Rectal cancer) 47 125 36 21 January 2019 7
RoLaCaRT-1  (Colorectal Cancer) 8 50 12 06 August 2021 8
SPAR (Rectal cancer) 94 222 48 13 April 2018 14

 

Share